Skip to main content

Anavex Life Sciences Corp.

AVXL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001314052

No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Anavex Life Sciences Corp. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
141
+2 vs. Q4 2022
Shares held
27.1M
+131.5K (+0.5%) vs. Q4 2022
Total value
$232.3M
−$16.5M (−6.6%) vs. Q4 2022
New holders
18
42 more added
Sold out
16
40 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AVXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 141 institutions
Q1 2021: 108 institutionsQ2 2021: 127 institutionsQ3 2021: 136 institutionsQ4 2021: 149 institutionsQ1 2022: 139 institutionsQ2 2022: 150 institutionsQ3 2022: 148 institutionsQ4 2022: 139 institutionsQ1 2023: 141 institutionsQ2 2023: 144 institutionsQ3 2023: 143 institutionsQ4 2023: 153 institutionsQ1 2024: 147 institutionsQ2 2024: 141 institutionsQ3 2024: 145 institutionsQ4 2024: 169 institutionsQ1 2025: 181 institutionsQ2 2025: 178 institutionsQ3 2025: 186 institutionsQ4 2025: 186 institutionsQ1 2026: 190 institutionsQ2 2026: 180 institutions
Value heldQ1 2023: $232.3M
Q1 2021: $271.9MQ2 2021: $492.2MQ3 2021: $370.1MQ4 2021: $383.2MQ1 2022: $308.2MQ2 2022: $249.4MQ3 2022: $251.4MQ4 2022: $248.7MQ1 2023: $232.3MQ2 2023: $205.6MQ3 2023: $164.1MQ4 2023: $240.8MQ1 2024: $161.3MQ2 2024: $113.3MQ3 2024: $153.2MQ4 2024: $316.5MQ1 2025: $269.2MQ2 2025: $301.9MQ3 2025: $289.3MQ4 2025: $136.1MQ1 2026: $122.7MQ2 2026: $95.8M
Institutions holding AVXL and their total value by quarter
QuarterHoldersValue
Q2 2026180$95.8M
Q1 2026190$122.7M
Q4 2025186$136.1M
Q3 2025186$289.3M
Q2 2025178$301.9M
Q1 2025181$269.2M
Q4 2024169$316.5M
Q3 2024145$153.2M
Q2 2024141$113.3M
Q1 2024147$161.3M
Q4 2023153$240.8M
Q3 2023143$164.1M
Q2 2023144$205.6M
Q1 2023141$232.3M
Q4 2022139$248.7M
Q3 2022148$251.4M
Q2 2022150$249.4M
Q1 2022139$308.2M
Q4 2021149$383.2M
Q3 2021136$370.1M
Q2 2021127$492.2M
Q1 2021108$271.9M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Anavex Life Sciences Corp.; share changes are against Q4 2022.

Institutions holding AVXL in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
DekaBank Deutsche Girozentrale55,000$449.0K0.00%00.0%Unchanged
JPMorgan Chase & Co57,722$495.0K0.00%+13,748+31.3%Added
Trexquant Investment LP59,695$511.6K0.01%−123,418−67.4%Reduced
Simplex Trading, LLC61,205$524.0K0.02%+61,205New
AllSquare Wealth Management LLC65,956$565.2K0.37%00.0%Unchanged
Virtu Financial LLC68,365$586.0K0.06%+38,751+130.9%Added
Hennion & Walsh Asset Management, Inc.70,558$605.0K0.04%−1,658−2.3%Reduced
Millennium Management LLC78,648$674.0K0.00%−754,876−90.6%Reduced
Cetera Advisor Networks LLC78,845$675.7K0.00%+9,287+13.4%Added
State of Wisconsin Investment Board82,688$708.6K0.00%+9,366+12.8%Added
Hikari Power Ltd85,585$733.0K0.07%00.0%Unchanged
Profund Advisors LLC85,912$736.3K0.05%+85,912New
Commonwealth Equity Services, LLC87,770$752.0K0.00%−3,245−3.6%Reduced
Credit Suisse AG89,163$764.1K0.00%+4,191+4.9%Added
Rhumbline Advisers89,519$767.0K0.00%+3,227+3.7%Added
Alliancebernstein L.P.89,600$767.9K0.00%00.0%Unchanged
California State Teachers Retirement System94,198$807.3K0.00%−1,116−1.2%Reduced
ExodusPoint Capital Management, LP96,585$828.0K0.01%−40,532−29.6%Reduced
UBS Asset Management Americas Inc96,924$830.6K0.00%+96,924New
Wells Fargo & Company159,578$1.37M0.00%+69,415+77.0%Added
Swiss National Bank168,300$1.44M0.00%−19,900−10.6%Reduced
BNP Paribas Arbitrage, SA170,896$1.46M0.00%+40,815+31.4%Added
Two Sigma Advisers, LP180,600$1.55M0.00%+71,500+65.5%Added
UBS Group AG182,350$1.56M0.00%−132,321−42.1%Reduced
Barclays PLC189,613$1.62M0.00%+179,613+1,796.1%Added
Nuveen Asset Management, LLC211,402$1.81M0.00%−9,678−4.4%Reduced
Bank of New York Mellon Corp254,523$2.18M0.00%+6,049+2.4%Added
Two Sigma Investments, LP260,030$2.23M0.01%+115,258+79.6%Added
Morgan Stanley261,486$2.24M0.00%−121,997−31.8%Reduced
Citigroup Inc377,924$3.24M0.00%+166,608+78.8%Added
Rafferty Asset Management, LLC465,255$3.99M0.03%+501+0.1%Added
Nwam LLC548,237$4.70M0.48%+548,237New
Charles Schwab Investment Management Inc560,043$4.80M0.00%−5,645−1.0%Reduced
Susquehanna International Group, LLP608,794$5.22M0.01%+233,906+62.4%Added
Goldman Sachs Group Inc671,812$5.76M0.00%−31,093−4.4%Reduced
Northern Trust Corp727,008$6.23M0.00%−1710.0%Reduced
Bank of America Corp836,775$7.17M0.00%+330,321+65.2%Added
Geode Capital Management, LLC1,452,878$12.5M0.00%+47,414+3.4%Added
Vanguard Group Inc4,170,604$35.7M0.00%+26,104+0.6%Added
State Street Corp5,677,376$48.7M0.00%−135,229−2.3%Reduced
BlackRock Inc.5,737,650$49.2M0.00%+159,491+2.9%Added
Pier Capital, LLC0$00.00%−280,854−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−119,600−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−46,190−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−34,350−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−29,259−100.0%Sold out
Janney Montgomery Scott LLC0$00.00%−24,060−100.0%Sold out
Squarepoint Ops LLC0$00.00%−21,810−100.0%Sold out
Quantamental Technologies LLC0$00.00%−18,534−100.0%Sold out
Miracle Mile Advisors, LLC0$00.00%−10,547−100.0%Sold out
Quantbot Technologies LP0$00.00%−2,800−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−2,700−100.0%Sold out
Cutler Group LP0$00.00%−1,500−100.0%Sold out
Fiduciary Alliance LLC0$00.00%−1,092−100.0%Sold out
Grey Fox Wealth Advisors, LLC0$00.00%−300−100.0%Sold out
GWM Advisors LLC0$00.00%−140−100.0%Sold out
Leonteq Securities AG0$00.00%−1−100.0%Sold out